Pregled bibliografske jedinice broj: 1278977
The prognostic significance of Nectin-2 and Nectin-4 expression in glial tumors
The prognostic significance of Nectin-2 and Nectin-4 expression in glial tumors // Pathology, research and practice, 244 (2023) doi:10.1016/j.prp.2023.154416 (međunarodna recenzija, članak, znanstveni)
CROSBI ID: 1278977 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
The prognostic significance of Nectin-2 and Nectin-4
expression in glial tumors
Autori
Dekanić, Andrea ; Babarović, Emina ; Kučan Brlić, Paola ; Knežić, Matija ; Savić Vuković, Anita ; Mazor, Marija ; Jonjić, Nives
Izvornik
Pathology, research and practice (0344-0338) 244
(2023);
X, 0
Vrsta, podvrsta i kategorija rada
Radovi u časopisima, članak, znanstveni
Ključne riječi
Glioma ; Nectins ; Nectin-2 ; Nectin-4 ; Immunohistochemistry
Sažetak
Glial tumors are the most frequent neoplasms of the central nervous system in adults and despite recent advances in diagnosis and treatment of the disease, the prognosis of glioma is poor. Therefore, there is a great need to identify new prognostic factors and potential immunotherapeutic targets. Members of the Nectin family of proteins are gaining significant attention as possible diagnostic and immunotherapeutic targets in many solid tumors, but they have not been extensively investigated in glial tumors. The aim of the present study was to evaluate the expression of Nectin-2 and Nectin-4 in glial tumors of different grades, and to assess their prognostic value. The results showed heterogeneous expression of Nectin- 2 and Nectin-4 in tumor cells and neuropil, with significantly higher Nectin-2 expression compared to Nectin-4, but without differences among tumor grades. In addition, the expression of Nectin-2 and Nectin-4 was associated with shorter survival times in patients with grade II/III gliomas. These results suggest that Nectin-2 and Nectin-4 expression may be used as an independent prognostic indicator for patients with II/III gliomas. This study contributes to the development of personalized care for patients with glioma and provides a basis for further research on nectin- based immunotherapy for brain tumors.
Izvorni jezik
Engleski
POVEZANOST RADA
Profili:
Emina Babarović
(autor)
Marija Mazor
(autor)
Nives Jonjić
(autor)
Paola Kučan Brlić
(autor)
Andrea Dekanić
(autor)
Citiraj ovu publikaciju:
Časopis indeksira:
- Current Contents Connect (CCC)
- Web of Science Core Collection (WoSCC)
- Science Citation Index Expanded (SCI-EXP)
- SCI-EXP, SSCI i/ili A&HCI
- Scopus
- MEDLINE